X Bioscience PCL (BKK:XBIO-W7) Change In Payables And Accrued Expense : ฿24.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 2025. Start your Free Trial

What is X Bioscience PCL Change In Payables And Accrued Expense?

X Bioscience PCL's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ฿1.4 Mil. It means X Bioscience PCL's Accounts Payable & Accrued Expense increased by ฿1.4 Mil from Dec. 2024 to Mar. 2025 .

X Bioscience PCL's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ฿38.3 Mil. It means X Bioscience PCL's Accounts Payable & Accrued Expense increased by ฿38.3 Mil from Dec. 2023 to Dec. 2024 .

X Bioscience PCL Change In Payables And Accrued Expense Historical Data

The historical data trend for X Bioscience PCL's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL Change In Payables And Accrued Expense Chart

X Bioscience PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

19.75

35.27

100.50

-3.82

38.31

X Bioscience PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															15.62	4.43	6.29	11.97	1.43

X Bioscience PCL Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿24.1 Mil.

X Bioscience PCL Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

X Bioscience PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

XBIO:Thailand

Address

Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400

Website

https://www.xbio.co.th

X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.

X Bioscience PCL Headlines

No Headlines